Although EVTA is the preferred method of choice for treating saphenous-derived varicose veins, not everyone is a good candidate for EVTA. If the saphenous vein is tortuous, small, close to the skin, or fragmented from previous treatment efforts, one can instead use UGS.
Dr. Kanter helped pioneer this procedure back in the early 1990′s1-4, and has been performing UGS ever since. Under precise ultrasound guidance, several injections of an FDA-approved solution are made to the diseased saphenous veins, causing them to shrink and disappear over time. Usually performed in 1-2 visits, UGS is a good second choice when EVTA cannot be performed.
- Kanter A, Thibault PK. Saphenofemoral incompetence treated by ultrasound-guided sclerotherapy. Dermatol Surg 1996;22:648-52.
- Kanter A. Clinical determinants of ultrasound-guided sclerotherapy outcome, Part I: The effects of age, gender, and vein size. Dermatol Surg 1998;24:131-135.
- Kanter A. Clinical determinants of ultrasound-guided sclerotherapy outcome. Part II: In search of the ideal injectate volume. Dermatol Surg 1998:24:136-140.
- Kanter A, Gardner M, Isaacs M. Identification of arteriovenous anastomoses by duplex ultrasound: implications for the treatment of varicose veins. Dermatol Surg 1995;21:885-9.